Clinical Trial

Vitamin D, Epigallocatechin Gallate, D-chiro-inositol and Vitamin B6 in Uterine Fibroid

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 12, 2026 (before its estimated March 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
The study will evaluate the impact on uterine fibroids' volume of a combination of natural molecules including Epigallocatechin gallate, Vitamin D, D-chiro-inositol and Vitamin B6. The patients will be evaluated at baseline and after three months of treatment with placebo or product.
Protocol Amendment History 5 amendments
This ClinicalTrials.gov record has been amended 5 times since 2022-07-04; most recent amendment 2026-02-10.
Trial Details
NCT Number NCT05448365
Lead Sponsor Lo.Li.Pharma s.r.l
Conditions Uterine Fibroids, D-chiro-inositol, Inositol, Epigallocatechin Gallate, Vitamin D, Vitamin B6
Enrollment 60 participants
Start Date 2022-07-01
Primary Completion 2026-03-01 (estimated)
Study Completion 2026-07-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-12